miR-23b-3p MET COMPOSITION FOR INHIBITING METASTASIS OF HEPATOCELLULAR CARCINOMA CONTAINING miR-23b-3p AND MET INHIBITOR AS ACTIVE INGREDIENTS

摘要

The present invention relates to a pharmaceutical composition for preventing or inhibiting metastasis of hepatocellular carcinoma, and a composition, kit, and the like for diagnosis and prediction of metastasis, and more particularly, including miR-23b-3p and MET inhibitor, epithelial mesenchymal of hepatocellular carcinoma cells A pharmaceutical composition for preventing or inhibiting metastasis of hepatocellular carcinoma, which can effectively prevent and inhibit hepatocellular carcinoma and metastasis thereof by inhibiting migration, a composition for diagnosing the hepatocellular carcinoma and metastasis thereof, a kit comprising the composition, and It relates to a method of providing information on the diagnosis of hepatocellular carcinoma and metastasis or prognosis of hepatocellular carcinoma.